Active Ingredient(s):Glatiramer FDA Approved: * December 20, 1996 Pharm Company: *TEVA Category:Multiple Sclerosis
Glatiramer acetate (also known as Copolymer 1, Cop-1), sold under the brand name Copaxone among others, is an immunomodulator medication used to treat multiple sclerosis. Glatiramer acetate is approved in the United States to reduce the frequency of relapses, but not for reducing the progression of disability. Observational studies, but not randomized controlled trials, suggest that it may reduce progression of disability. While a conclusive diagnosis of ...
* May have multiple approval dates, manufacturers, or labelers. 4 Discussions